ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Nuveen Select Tax Free Income

Nuveen Select Tax Free Income (NXP)

14.91
0.00
(0.00%)
Closed 02 February 8:00AM
14.87
-0.04
(-0.27%)
After Hours: 8:58AM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
14.87
Bid
-
Offer
-
Volume
122,720
14.86 Day's Range 15.03
13.7907 52 Week Range 15.25
Market Cap
Previous Close
14.91
Open
14.91
Last Trade
1717
@
14.91
Last Trade Time
Financial Volume
US$ 1,834,968
VWAP
14.9525
Average Volume (3m)
83,321
Shares Outstanding
46,799,113
Dividend Yield
4.10%
PE Ratio
22.15
Earnings Per Share (EPS)
0.67
Revenue
30.18M
Net Profit
31.4M

About Nuveen Select Tax Free Income

The Fund's investment objective is current income exempt from regular federal income tax, consistent with preservation of capital. The Fund invests in municipal securities that are exempt from federal income taxes. The Fund invests at least 80% of its managed assets in municipal securities rated inv... The Fund's investment objective is current income exempt from regular federal income tax, consistent with preservation of capital. The Fund invests in municipal securities that are exempt from federal income taxes. The Fund invests at least 80% of its managed assets in municipal securities rated investment grade at the time of investment, or, if they are unrated, are judged by the manager to be of comparable quality. The Fund may invest up to 20% of its managed assets in municipal securities rated below investment quality or judged by the manager to be of comparable quality, of which up to 10% of its managed assets may be rated below B-/B3 or of comparable quality. Show more

Sector
Unit Inv Tr, Closed-end Mgmt
Industry
Unit Inv Tr, Closed-end Mgmt
Website
Headquarters
Boston, Massachusetts, USA
Founded
-
Nuveen Select Tax Free Income is listed in the Unit Inv Tr, Closed-end Mgmt sector of the New York Stock Exchange with ticker NXP. The last closing price for Nuveen Select Tax Free I... was US$14.91. Over the last year, Nuveen Select Tax Free I... shares have traded in a share price range of US$ 13.7907 to US$ 15.25.

Nuveen Select Tax Free I... currently has 46,799,113 shares in issue. The market capitalisation of Nuveen Select Tax Free I... is US$697.77 million. Nuveen Select Tax Free I... has a price to earnings ratio (PE ratio) of 22.15.

NXP Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.01-0.067204301075314.8814.9914.836248314.87856002CS
4-0.08-0.53511705685614.9515.214.69017846614.87057479CS
120.16911.1502697113814.700915.214.458332114.79627901CS
260.120.81355932203414.7515.2514.458216914.85447594CS
520.392.6933701657514.4815.2513.79078011714.62829378CS
156-0.2-1.3271400132715.0715.3512.869655614.18750946CS
260-1.99-11.80308422316.8618.8912.77257714.61505416CS

NXP - Frequently Asked Questions (FAQ)

What is the current Nuveen Select Tax Free I... share price?
The current share price of Nuveen Select Tax Free I... is US$ 14.87
How many Nuveen Select Tax Free I... shares are in issue?
Nuveen Select Tax Free I... has 46,799,113 shares in issue
What is the market cap of Nuveen Select Tax Free I...?
The market capitalisation of Nuveen Select Tax Free I... is USD 697.77M
What is the 1 year trading range for Nuveen Select Tax Free I... share price?
Nuveen Select Tax Free I... has traded in the range of US$ 13.7907 to US$ 15.25 during the past year
What is the PE ratio of Nuveen Select Tax Free I...?
The price to earnings ratio of Nuveen Select Tax Free I... is 22.15
What is the cash to sales ratio of Nuveen Select Tax Free I...?
The cash to sales ratio of Nuveen Select Tax Free I... is 23.05
What is the reporting currency for Nuveen Select Tax Free I...?
Nuveen Select Tax Free I... reports financial results in USD
What is the latest annual turnover for Nuveen Select Tax Free I...?
The latest annual turnover of Nuveen Select Tax Free I... is USD 30.18M
What is the latest annual profit for Nuveen Select Tax Free I...?
The latest annual profit of Nuveen Select Tax Free I... is USD 31.4M
What is the registered address of Nuveen Select Tax Free I...?
The registered address for Nuveen Select Tax Free I... is 155 FEDERAL, STREET STE 700, BOSTON, MASSACHUSETTS, 02110
What is the Nuveen Select Tax Free I... website address?
The website address for Nuveen Select Tax Free I... is www.nuveen.com
Which industry sector does Nuveen Select Tax Free I... operate in?
Nuveen Select Tax Free I... operates in the UNIT INV TR, CLOSED-END MGMT sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MBIMBIA Inc
US$ 7.11
(15.42%)
2.37M
ALURAllurion Technologies Inc
US$ 6.07
(13.46%)
581.31k
SESSES AI Corporation
US$ 1.19
(13.33%)
25.04M
ENFYEnlightify Inc
US$ 1.36
(12.40%)
95.7k
LITBLightInTheBox Holding Co Ltd
US$ 1.155
(12.14%)
17.6k
DECKDeckers Outdoor
US$ 177.46
(-20.46%)
15.04M
BZHBeazer Homes USA Inc New
US$ 22.18
(-19.93%)
2.11M
VSTSVestis Corporation
US$ 14.00
(-11.62%)
6.16M
KOREKORE Group Holdings Inc
US$ 2.29
(-9.13%)
36.39k
NOVASunnova Energy International Inc
US$ 2.565
(-9.04%)
14.63M
FFord Motor Company
US$ 10.08
(-0.79%)
103.95M
QBTSD Wave Quantum Inc
US$ 5.94
(5.32%)
74.97M
BBDBanco Bradesco SA
US$ 2.12
(0.47%)
55.74M
NUNu Holdings Ltd
US$ 13.25
(-1.41%)
47.85M
VZVerizon Communications Inc
US$ 39.39
(-0.20%)
44.69M

Discussion

View Full Feed
Kam8 Kam8 3 hours ago
LP just doesn't accept Settlement and go discovery🤞😆🤞, I don't think MMs want discovery so they might accept big money for settlement. 😆😆
NWBO
manibiotech manibiotech 3 hours ago
Agree
Usual few will pump this anyway 
NWBO
manibiotech manibiotech 3 hours ago
lol 
The ceiling has already been put at 40M shares
So dream on
NWBO
Deportes Deportes 3 hours ago
Gfy is that better?
ENZC
Hicham007 Hicham007 3 hours ago
Painful but nothing new...

I have averaged down my portfolio to 6.6$ down from 9.8 and I have now 140k shares and i am ready to increase it to 200k if the SP continues on  dropping.  By now Iova is my only stock market investment so we can say all In...

I am ready finan
IOVA
jammy32 jammy32 3 hours ago
As soon as Trump the genius mentioned Tariffs on pharmaceuticals, this puppy got sick and dropped seven cents. Not good. Shouldn’t Nasrat tell us what this means for Elite. Are we subject to the tariffs where is the API from. Is this a good thing or bad thing. Does nasrat know. Does he
API
rosemountbomber rosemountbomber 3 hours ago
Sleven am I understanding correctly that the Generics get their API from China and Amarin doesn't?
API
BlazingStocks BlazingStocks 3 hours ago
$ILLR Triller CEO Sean Kim joins Yahoo Finance to discuss the fight for TikTok's market share and the outlook for the creator economy:https://x.com/YahooFinance/status/1885453406485033258?t=ldZluPpc4DCzgBoH3GagOA&s=19
ILLR
barnstormer barnstormer 3 hours ago
OK Zadie, the judge only allowed a lousy 40 million shares. Still, consider the following (quick back of the envelope math)

40,000,000 shares / (2752(avg daily volume) x 252 (avg yearly trading days) = 700,104 avg yearly shares traded
40,000,000 shares / 700,104 = 57.14 years
NWBO
BlazingStocks BlazingStocks 3 hours ago
Thank you for sharing this! 
ILLR
VMLG17 VMLG17 3 hours ago
And they’d be stupid if they didn’t settle. If a jury learns that the MMs have continued spoofing after the lawsuit was filed, then damages could be more than any settlement amount, not to mention criminal charges later.
NWBO
Macod Macod 3 hours ago
CHANGE in outstanding shares. First change in over a year. Should be more shares reflected with next update. Those lucky enough to buy privates be on the lookout for your certs

O/S 526,142,269
Restricted 297,633,160
Unrestricted 228,509,109

Increase of 7,6
MRGE
mascale mascale 3 hours ago
Hiru Prepared: Likely for new JORC, 2025, Canadian standard less likely needed. ERM is noted in Hiru basis reporting. "Resource reporting and compliance: we prepare mineral resource reports in accordance with international reporting standards such as NI 43-101, JORC, and CIM. Our experts ensure t
HIRU
stealofadeal stealofadeal 3 hours ago
$ BLTHD The way this is looking with not much on the offer we are going much higher. We are sitting way under the radar. I saw 12.00 the third market maker down on the ask.
BLTHD
nowwhat2 nowwhat2 3 hours ago
scoop um up right at black swan.
XRPUSD
loophole lawyer loophole lawyer 3 hours ago
The 3 most important letters for GTCH…..P,C,T……Checkmate
GTCH
Preciouslife1 Preciouslife1 3 hours ago
https://www.mlb.com/news/mets-counting-on-trade-deadline-additions
jxyzobrien jxyzobrien 3 hours ago
hope you are well
sounds like your company is doing great
say hi when you can
flipper44 flipper44 3 hours ago
The court’s R&R did conclude and preserve NWBO illegal spoofing claims alleged to have been committed by defendants.
NWBO
x993231 x993231 3 hours ago
He does like to make a mountain out of a mole hill, but that is what he gets paid to do.  I have him and many of his alternate ID's on ignore.  He is good at asking, why, why, why.  

X. Yves is good at doing his thing.  Funny remember when Lebby said if I don't perform by the end of t
LWLG
havnagoodtime havnagoodtime 3 hours ago
So, what is the short interest and the FTD report on DPLS? Thanks in advance.
DPLS
MartinLutherKing MartinLutherKing 3 hours ago
E Pluribus Unum brothers The one and only
FDA Approves Phase 1/2 Trial for TransCode's TTX-MC138 in Advanced Tumor Patients
3 June 2024
TransCode Therapeutics, a company dedicated to the advancement of RNA therapeutics in oncology, has received the green light from the U.S. Food
RNAZ
gladeshawk gladeshawk 3 hours ago
AIRI>>>NEWS. Not a penny play but worth a look. HAWK

https://finance.yahoo.com/news/air-industries-group-closes-fiscal-120000021.html
AIRI
MartinLutherKing MartinLutherKing 3 hours ago
E Pluribus Unum brothers The one and only
FDA Approves Phase 1/2 Trial for TransCode's TTX-MC138 in Advanced Tumor Patients
3 June 2024
TransCode Therapeutics, a company dedicated to the advancement of RNA therapeutics in oncology, has received the green light from the U.S. Food
RNAZ
vein vein 3 hours ago
Hey Bubb, I see the cfo received shares , but I don't see the CEO s4??? 
CKPT